A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Clinical trial NCT06916806 · RECRUITING
Trial details
- NCT number
- NCT06916806
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-05-05
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.